• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

子宫肉瘤的临床方面(作者译)

[Clinical aspects of uterine sarcomas (author's transl)].

作者信息

Stegner H E

出版信息

Pathol Res Pract. 1980 Oct;169(2):120-6. doi: 10.1016/s0344-0338(80)80112-9.

DOI:10.1016/s0344-0338(80)80112-9
PMID:7443570
Abstract

Uterine sarcomas constitute 1% to 3% of all uterine cancers. There are three main histological varieties: endometrial stromal sarcoma, leiomyosarcoma, and mixed mesodermal (Müllerian) sarcoma. The tumors are characterized by local aggressiveness and early dissemination. According to the literature, 5 year survival rates range from 3 to 75% (!). This wide range reflects great prognostic differences in the various histologic types. On the other hand it may be due to discrepancies in histopathological evaluation. Radical surgery is the most effective therapy. In early stages it leads to 5 year survival rates of up to 88%. Adjuvant irradiation may increase the control of disease in the pelvis but has proven to be of little influence on the final outcome. The histologic variants show great differences in radiosensitivity. In endometrial stromal sarcomas adjuvant radiation therapy apparently can improve the treatment results. By contrast mixed mesodermal sarcomas are highly radioresistent. There is poor knowledge on the effectiveness of cytotoxic agents on uterine sarcomas. Objective remission of distant metastasis has been observed following treatment with cytotoxic antibiotics (Adriamycin).

摘要

子宫肉瘤占所有子宫癌的1%至3%。主要有三种组织学类型:子宫内膜间质肉瘤、平滑肌肉瘤和混合性中胚叶(苗勒氏)肉瘤。这些肿瘤的特点是局部侵袭性和早期扩散。根据文献,5年生存率在3%至75%之间(!)。如此大的范围反映了不同组织学类型在预后方面的巨大差异。另一方面,这可能是由于组织病理学评估存在差异。根治性手术是最有效的治疗方法。在早期阶段,其可使5年生存率高达88%。辅助放疗可能会增加对盆腔疾病的控制,但已证明对最终结果影响不大。组织学变体在放射敏感性方面表现出很大差异。在子宫内膜间质肉瘤中,辅助放疗显然可以改善治疗效果。相比之下,混合性中胚叶肉瘤具有高度放射抗性。关于细胞毒性药物对子宫肉瘤的有效性了解甚少。在用细胞毒性抗生素(阿霉素)治疗后,观察到远处转移有客观缓解。

相似文献

1
[Clinical aspects of uterine sarcomas (author's transl)].子宫肉瘤的临床方面(作者译)
Pathol Res Pract. 1980 Oct;169(2):120-6. doi: 10.1016/s0344-0338(80)80112-9.
2
Analysis of clinicopathologic prognostic factors for 157 uterine sarcomas and evaluation of a grading score validated for soft tissue sarcoma.157例子宫肉瘤的临床病理预后因素分析及软组织肉瘤验证分级评分的评估
Cancer. 2000 Mar 15;88(6):1425-31.
3
Clinical outcome and prognostic factors in 100 cases of uterine sarcoma: experience in Helsinki University Central Hospital 1990-2001.100例子宫肉瘤的临床结局及预后因素:赫尔辛基大学中心医院1990 - 2001年的经验
Gynecol Oncol. 2008 Oct;111(1):74-81. doi: 10.1016/j.ygyno.2008.06.002. Epub 2008 Jul 26.
4
Uterine sarcoma: prognostic factors and treatment evaluation.子宫肉瘤:预后因素与治疗评估
Isr Med Assoc J. 2011 Feb;13(2):76-9.
5
[Uterine sarcomas: clinical and histopathological aspects. Report on 15 cases].[子宫肉瘤:临床与组织病理学特征。15例报告]
Gynecol Obstet Fertil. 2008 Jun;36(6):628-35. doi: 10.1016/j.gyobfe.2008.03.012. Epub 2008 Jun 5.
6
Outcome and prognosis in uterine sarcoma and malignant mixed Mullerian tumor.子宫肉瘤和恶性苗勒管混合瘤的结局与预后
Arch Gynecol Obstet. 2016 Aug;294(2):343-51. doi: 10.1007/s00404-015-3993-6. Epub 2015 Dec 28.
7
Uterine sarcoma: clinicopathological characteristics, treatment and outcome in Iran.子宫肉瘤:伊朗的临床病理特征、治疗及预后
Asian Pac J Cancer Prev. 2008 Jul-Sep;9(3):421-6.
8
Treatment of patients with sarcoma of the uterus.子宫肉瘤患者的治疗。
Eur J Gynaecol Oncol. 1990;11(3):225-31.
9
Sarcomas of the uterus: a clinicopathologic study of 119 patients.子宫肉瘤:119例患者的临床病理研究
Obstet Gynecol. 1986 Mar;67(3):417-24.
10
Uterine sarcoma: a clinicopathological study of 93 cases.子宫肉瘤:93例临床病理研究
Eur J Gynaecol Oncol. 1997;18(3):192-5.